BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8319584)

  • 1. Targeted developmental overexpression of calmodulin induces proliferative and hypertrophic growth of cardiomyocytes in transgenic mice.
    Gruver CL; DeMayo F; Goldstein MA; Means AR
    Endocrinology; 1993 Jul; 133(1):376-88. PubMed ID: 8319584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted expression of calmodulin increases ventricular cardiomyocyte proliferation and deoxyribonucleic acid synthesis during mouse development.
    Colomer JM; Terasawa M; Means AR
    Endocrinology; 2004 Mar; 145(3):1356-66. PubMed ID: 14670993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo.
    Passier R; Zeng H; Frey N; Naya FJ; Nicol RL; McKinsey TA; Overbeek P; Richardson JA; Grant SR; Olson EN
    J Clin Invest; 2000 May; 105(10):1395-406. PubMed ID: 10811847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of calmodulin induces cardiac hypertrophy by a calcineurin-dependent pathway.
    Obata K; Nagata K; Iwase M; Odashima M; Nagasaka T; Izawa H; Murohara T; Yamada Y; Yokota M
    Biochem Biophys Res Commun; 2005 Dec; 338(2):1299-305. PubMed ID: 16256941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional abrogation of p53 is required for T-Ag induced proliferation in cardiomyocytes.
    Huh NE; Pasumarthi KB; Soonpaa MH; Jing S; Patton B; Field LJ
    J Mol Cell Cardiol; 2001 Aug; 33(8):1405-19. PubMed ID: 11448130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic elevation of calmodulin in the ventricles of transgenic mice increases the autonomous activity of calmodulin-dependent protein kinase II, which regulates atrial natriuretic factor gene expression.
    Colomer JM; Means AR
    Mol Endocrinol; 2000 Aug; 14(8):1125-36. PubMed ID: 10935538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tetracycline-inducible CaM kinase II silences hypertrophy-sensitive gene expression in rat neonate cardiomyocytes.
    Valencia TG; Roberts LD; Zeng H; Grant SR
    Biochem Biophys Res Commun; 2000 Aug; 274(3):803-10. PubMed ID: 10924357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac-specific overexpression of diacylglycerol kinase zeta prevents Gq protein-coupled receptor agonist-induced cardiac hypertrophy in transgenic mice.
    Arimoto T; Takeishi Y; Takahashi H; Shishido T; Niizeki T; Koyama Y; Shiga R; Nozaki N; Nakajima O; Nishimaru K; Abe J; Endoh M; Walsh RA; Goto K; Kubota I
    Circulation; 2006 Jan; 113(1):60-6. PubMed ID: 16380548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiomyocyte growth regulation by Ca(2+)-calmodulin.
    Graver CL; George SE; Means AR
    Trends Cardiovasc Med; 1992; 2(6):226-31. PubMed ID: 21239246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Akt induces enhanced myocardial contractility and cell size in vivo in transgenic mice.
    Condorelli G; Drusco A; Stassi G; Bellacosa A; Roncarati R; Iaccarino G; Russo MA; Gu Y; Dalton N; Chung C; Latronico MV; Napoli C; Sadoshima J; Croce CM; Ross J
    Proc Natl Acad Sci U S A; 2002 Sep; 99(19):12333-8. PubMed ID: 12237475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial hypertrophy in transgenic mice overexpressing human interleukin 1alpha.
    Isoda K; Kamezawa Y; Tada N; Sato M; Ohsuzu F
    J Card Fail; 2001 Dec; 7(4):355-64. PubMed ID: 11782860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SRF-dependent gene expression in isolated cardiomyocytes: regulation of genes involved in cardiac hypertrophy.
    Nelson TJ; Balza R; Xiao Q; Misra RP
    J Mol Cell Cardiol; 2005 Sep; 39(3):479-89. PubMed ID: 15950986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocardial expression of a constitutively active alpha 1B-adrenergic receptor in transgenic mice induces cardiac hypertrophy.
    Milano CA; Dolber PC; Rockman HA; Bond RA; Venable ME; Allen LF; Lefkowitz RJ
    Proc Natl Acad Sci U S A; 1994 Oct; 91(21):10109-13. PubMed ID: 7937846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HSP75 protects against cardiac hypertrophy and fibrosis.
    Zhang Y; Jiang DS; Yan L; Cheng KJ; Bian ZY; Lin GS
    J Cell Biochem; 2011 Jul; 112(7):1787-94. PubMed ID: 21381076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyomavirus large T-antigen expression in heart of transgenic mice causes cardiomyopathy.
    Chalifour LE; Gomes ML; Wang NS; Mes-Masson AM
    Oncogene; 1990 Nov; 5(11):1719-26. PubMed ID: 2176284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The deltaC isoform of CaMKII is activated in cardiac hypertrophy and induces dilated cardiomyopathy and heart failure.
    Zhang T; Maier LS; Dalton ND; Miyamoto S; Ross J; Bers DM; Brown JH
    Circ Res; 2003 May; 92(8):912-9. PubMed ID: 12676814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transgenic myocardial overexpression of prokineticin receptor-2 (GPR73b) induces hypertrophy and capillary vessel leakage.
    Urayama K; Dedeoglu DB; Guilini C; Frantz S; Ertl G; Messaddeq N; Nebigil CG
    Cardiovasc Res; 2009 Jan; 81(1):28-37. PubMed ID: 18806277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of norepinephrine-induced cardiac hypertrophy in s100beta transgenic mice.
    Tsoporis JN; Marks A; Kahn HJ; Butany JW; Liu PP; O'Hanlon D; Parker TG
    J Clin Invest; 1998 Oct; 102(8):1609-16. PubMed ID: 9788975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Casein kinase-2α1 induces hypertrophic response by phosphorylation of histone deacetylase 2 S394 and its activation in the heart.
    Eom GH; Cho YK; Ko JH; Shin S; Choe N; Kim Y; Joung H; Kim HS; Nam KI; Kee HJ; Kook H
    Circulation; 2011 May; 123(21):2392-403. PubMed ID: 21576649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pressure-independent cardiac hypertrophy in mice with cardiomyocyte-restricted inactivation of the atrial natriuretic peptide receptor guanylyl cyclase-A.
    Holtwick R; van Eickels M; Skryabin BV; Baba HA; Bubikat A; Begrow F; Schneider MD; Garbers DL; Kuhn M
    J Clin Invest; 2003 May; 111(9):1399-407. PubMed ID: 12727932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.